エンウェーブ、2024年第2四半期連結中間決算を発表
2024年5月24日、BC州デルタ
today reported the Company’s consolidated interim financial results for the second quarter ended March 31, 2024.
特に断りのない限り、数値はすべて千単位でCAD表示。
- Reported royalty revenues of $414, representing an increase of $137 relative to the comparable period in the prior year. Royalties for the six months ending March 31, 2024 were $894 compared to $690 for the same period ending March 31, 2023, an increase of $204 or 30%. Royalties grew due to increased partner product sales and production offset by a decrease in exclusivity fees.
- Reported revenue for Q2 2023 of $663, representing a decrease of $3,972 relative to the comparable period in the prior year. The decrease was related to fewer machine sales and machines in fabrication due to the inherent volatility in large-scale Radiant Energy Vacuum (“REV™”) machine orders.
- Reported Selling, General & Administrative (“SG&A”) costs (including Research & Development (“R&D”)) of $1,389 which was consistent with the comparable period in the prior year. SG&A costs for the six months ending March 31, 2024 were $2,652 compared to $2,954 for the same period ending March 31, 2023, a decrease of $302 or 10%. The Company continues to make concerted efforts to manage discretionary spending.
- Gross margin for the three months ended Q2 2024 was -25% compared to 49% for the three months ended Q2 2023. The decrease in margin was a result of fewer machine sales and machines in fabrication to absorb fixed overhead costs.
- Reported an Adjusted EBITDA(1) loss of $1,268 for Q2 2024, compared to an Adjusted EBITDA(1) profit of $1,151 in the same period in the prior year.
連結業績：
| ($ ‘000s) | Three months ended March 31, | Six months ended March 31, | |||||
| 2024 | 2023 | Change % | 2024 | 2023 | Change % | ||
| Revenues | 663 | 4,635 | (86%) | 1,925 | 7,420 | (74%) | |
| Direct costs | (830) | (2,371) | (65%) | (1,859) | (4,127) | (55%) | |
| Gross margin | (167) | 2,264 | (107%) | 66 | 3,293 | (98%) | |
| Operating expenses | |||||||
| General and administration | 565 | 697 | (19%) | 1,076 | 1,252 | (14%) | |
| Sales and marketing | 440 | 276 | 59% | 791 | 890 | (11%) | |
| Research and development | 384 | 415 | (7%) | 785 | 812 | (3%) | |
| 1,389 | 1,388 | 0% | 2,652 | 2,954 | (10%) | ||
| Net income (loss) continuing operations | (1,559) | 687 | (327%) | (2,703) | (56) | (4727%) | |
| Net income (loss) discontinued operations | 148 | (3,386) | 104% | (3) | (4,672) | 100% | |
| Adjusted EBITDA(1) | (1,268) | 1,151 | (210%) | (2,024) | 895 | (326%) | |
| Loss per share: | |||||||
| Basic and diluted – continuous operations | $ (0.01) | $ 0.01 | $ (0.02) | $ 0.00 | |||
| Basic and diluted – discontinued operations | $ 0.00 | $ (0.03) | $ 0.00 | $ (0.04) | |||
| $ (0.01) | $ (0.02) | $ (0.02) | $ (0.04) | ||||
- Adjusted EBITDA is a non-IFRS financial measure. Refer to the Non-IFRS Financial Measures disclosure below for a reconciliation to the nearest IFRS equivalent.
EnWave’s consolidated interim financial statements and MD&A are available on SEDAR+ at www.sedarplus.ca and on the Company’s website www.enwave.net.
Significant Corporate Accomplishments in Q2 2024 and Subsequently:
- Signed an Equipment Purchase Agreement with an existing Royalty Partner for a 120kW REV™ dehydration machine to commercialize its own branded snack products and co-manufacture new snack and ingredient products with several major consumer packaged goods companies.
- Signed a Technology Evaluation and License Option Agreement with a North American multi-state cannabis company to evaluate REV™ Technology over other incumbent drying methods.
- Signed a toll manufacturing agreement with BranchOut Food Inc. to produce vegetable snack products on an interim basis at the Company’s REVworx facility in Delta, Canada.
- Signed a new royalty-bearing commercial license and equipment lease agreement for two 10kw REV™ machines with an established South American food manufacturer that currently sells health supplements, snacks, cereals, baked goods, among other products.
- Signed a Technology Evaluation and License Option Agreement with a North American food company led by a renowned chef with multiple Michelin Stars.
非IFRS財務指標：
This news release refers to Adjusted EBITDA which is a non-IFRS financial measure. We define Adjusted EBITDA as earnings before deducting amortization and depreciation, stock-based compensation, foreign exchange gain or loss, finance expense or income, income tax expense or recovery and non-recurring impairment, restructuring and severance charges, and discontinued operations. This measure is not necessarily comparable to similarly titled measures used by other companies and should not be construed as an alternative to net income or cash flow from operating activities as determined in accordance with IFRS. Please refer to the reconciliation between Adjusted EBITDA and the most comparable IFRS financial measure reported in the Company’s consolidated interim financial statements.
| Three months ended March 31, | Six months ended March 31, | |||||
| ($ ‘000s) | 2024 | 2023 | 2024 | 2023 | ||
| Net (loss) income after income tax | (1,411) | (2,699) | (2,706) | (4,728) | ||
| Amortization and depreciation | 288 | 276 | 563 | 565 | ||
| Stock-based compensation | 71 | 197 | 186 | 365 | ||
| Foreign exchange loss | (51) | (9) | (27) | 32 | ||
| Finance income | (54) | (33) | (106) | (79) | ||
| Finance expense | 37 | 33 | 63 | 68 | ||
| Discontinued operations | (148) | 3,386 | 3 | 4,672 | ||
| Adjusted EBITDA | (1,268) | 1,151 | (2,024) | 895 | ||
Non-IFRS financial measures should be considered together with other data prepared in accordance with IFRS to enable investors to evaluate the Company’s operating results, underlying performance and prospects in a manner similar to EnWave’s management. Accordingly, these non-IFRS financial measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. For more information, please refer to the Non-IFRS Financial Measures section in the Company’s MD&A available on SEDAR+ www.sedarplus.ca.
エンウェーブについて
EnWave社は、真空マイクロ波脱水の革新と応用の世界的リーダーです。EnWave社は、BC州デルタに本社を置き、強固な知的財産ポートフォリオを開発し、放射エネルギー真空(REV™)技術を完成させ、革新的なアイデアを、食品、製薬、大麻産業用の、実績のある、一貫した、拡張可能な乾燥ソリューションに変えました。
世界26カ国、5大陸にまたがる50社以上のロイヤリティ創出パートナーとともに、EnWaveのライセンスパートナーは、同社の特許技術、ライセンス機械、専門家の指導により、収益性の高い、これまでにないスナック菓子や食材を生み出し、既存商品の品質と一貫性を向上させ、無駄のない経営を実現し、より早く市場に投入している。
エンウェーブの戦略は、凍結乾燥、ラック乾燥、風乾よりも、より良く、より速く、より経済的に乾燥させ、エキサイティングな新製品を生産し、最適な水分レベルに最大7倍速く到達し、製品の味、食感、色、栄養価を向上させるという次のようなメリットを享受したいと考える食品製造業者と、ロイヤリティを伴う商業ライセンスを締結することである。
詳しくはEnWave.netをご覧ください。
エンウェーブ・コーポレーション
ブレント・チャールトン CFA
社長兼CEO
詳細はこちら：
ブレント・チャールトン、CFA、社長兼CEO、電話：+1 (778) 378-9616
E-mail: bcharleton@enwave.net
ディラン・マレイ、CFO、電話：+1 (778) 870-0729
E-mail:dmurray@enwave.net
TSXベンチャー取引所およびその規制サービスプロバイダー（この用語はTSXベンチャー取引所の方針で定義されています）は、本リリースの妥当性または正確性について責任を負いません。
